Interleukin Genetics' Q2 Revenues Rise 33 Percent | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Interleukin Genetics today reported that its second-quarter revenues rose 33 percent on higher genetic test sales.

The Waltham, Mass.-based firm brought in total revenues of $800,000 for the three months ended June 30, compared to $600,000 for the second quarter of 2010. Almost all of its revenues were from genetic test sales.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: Neanderthal-derived DNA linked to modern ailments, and more.

Japan needs to catch up on its gene-editing research efforts, the Japan News writes.

Hundreds of people have signed an online petition calling for zero tolerance to sexual harassment in the sciences.

Jeff Huber, former Google X senior vice president, joins Grail as its CEO.

Mar
03
Sponsored by
Agilent Technologies

This webinar will discuss the use of a hybrid capture-based FFPE DNA sequencing methodology with the potential for advancing precision oncology studies.